Tryggestad AMA, Axcrona K, Axcrona U, Bigalke I, et al. Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy. Prostate 2021 Nov 11. doi: 10.1002/pros.24267.
PMID: 34762317